Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil

Lowe FC, Brendler CB . Evaluation of the urologic patient. History physical examination, and urinalysis. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds). Campbell's Urology 6th Edition. WB Saunder Company: Philadelphia, PA 1992 chapter 8, 307–342

Rehman J, Benet A, Melman A . Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology 1998 51, 620–626

Schiavino D et al.. Imunologic findings in Peyronie's disease: a controlled study. Urology 1997 50, 766–768

Leffel MS . Is there an immunogenetic basis for Peyronie's disease? J Urol 1997 157, 295–297

El-Sakka AI et al.. Peyronie's disease is associated with an increase in transforming growth factor-B protein expression. J Urol 1997 158, 1391–1394

Chilton CP, Castle WM, Westwood CA, Pryor JP . Factors associated in the aetiology of Peyronie's disease. Br J Urol 1982 54, 748–750

Ralph DJ, Brooks MD, Bottazzo GF, Pryor JP . The treatment of Peyronie's disease with tamoxifen. Br J Urol 1992 70, 648–651

Rhoden EL et al.. Is there any association between Peyronie's disease and serum collagen markers? Int J Impot Res 2000 12, 302–304

Jordan GH, Schlossberg SM, Devine CJ . Surgery of the penis and urethra. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell's Urology, 7th edition. WB Sauders Company: Philadelphia, PA 1998 3, Chap 107, 3316–3394

Schwarzer U et al.. Prevalence of Peyronie's disease—results of an 8,000 men survey. AUA 2000 Annual Meeting.

Rosen RC, Cappelleri JC, Lipsky J, Peña BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999 11, 319–326

Rosen RC et al.. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49, 822–830

Iacono F et al.. Microstructural disorders of the tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction. J Urol 1993 150, 1806–1809

Dunsmuir WD . Francois de LaPeyronie (1678–1747): the man and the disease he described. Br J Urol 1996 78, 613–622

Telöken C et al.. Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 1999 162, 2003–2005

Devine CJ, Jordan GH, Shlossberg SM . Surgery of the penis and urethra. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds). Campbell's Urology, 6th edition. WB Saunder Company: Philadelphia, PA 1992 Chapter 83, 2957–3032

Altaffer LF, Jordan GH . Sonographic demonstration of Peyronie's disease. Urology 1981 27, 292–295

Smith BH . Subclinical Peyronie's disease. Am J Path 1969 52, 385–390

Lindsay MB et al.. The incidence of Peyronie's disease in Rochester, Minnesota 1950 through 1984. J Urol 1991 146, 1007–1009